Conception Chances with Male Hormonal Contraception
Male hormonal contraception (injectable testosterone ± progestin, gels, pills) is not yet commercially available but in clinical trials. Current options: condoms, vasectomy, withdrawal.
If Partner Uses Female Hormonal Contraception
- Perfect use: <0.1% pregnancy/year (implants, IUD); 0.3% (pill/patch/ring).
- Typical use: 0.1–7% depending on method.
- Mechanism: Suppress ovulation, thicken cervical mucus, thin endometrium.
If Partner Stops Hormonal Contraception
- Return to fertility: Immediate (IUD removal, implant removal, stopping pill/patch/ring) to months (DMPA injection: median 10 months).
- "Rebound fertility" transiently ↑ after stopping OCP – not well quantified.
If No Contraception
- Fertile window: 5 days before + day of ovulation (sperm survive 5 days, ovum 12–24 hrs).
- Peak conception probability: ~30% per cycle at peak fertility (age <30).
- Declines with age, anovulation, male factor, endometriosis, etc.
Key Point
Male hormonal contraception is experimental. Discuss current options with clinician. Semen analysis confirms vasectomy success. Female partner's method determines current pregnancy risk.
Infertility - Related Articles
- Blood Type and Marriage: Can a B Positive Man Marry a Girl?
- Understanding the Fetal-Placenta Connection: The Umbilical Cord
- Ovulation: Egg Release and Fertility Window
- Sensation of Bulging Membranes During Cervical Dilation
- Progesterone Deficiency: Impact on Ovulation & Fertility
- Miscarriage Presentation: Vaginal Bleeding as the Primary Symptom
- Onset of Gametogenesis: When Testes and Ovaries Begin Producing Reproductive Cells
